Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longboard Pharmaceuticals Inc (NQ: LBPH ) 32.85 -0.07 (-0.21%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 831,842 Open 33.93 Bid (Size) 28.50 (5) Ask (Size) 32.85 (2) Prev. Close 32.92 Today's Range 29.41 - 34.17 52wk Range 3.600 - 40.48 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) August 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates August 01, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Performance YTD +30.88% +30.88% 1 Month +2.95% +2.95% 3 Month +53.68% +53.68% 6 Month +65.83% +65.83% 1 Year +338.58% +338.58% More News Read More Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1 July 29, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Recap: Longboard Pharmaceuticals Q4 Earnings March 12, 2024 Via Benzinga Looking Into Longboard Pharmaceuticals's Recent Short Interest January 19, 2024 Via Benzinga 3 Russell 2000 Growth Stocks That Could Be Worth the Risk July 23, 2024 Via The Motley Fool Topics Economy Exposures Interest Rates Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 03, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Top 3 Health Care Stocks That May Crash This Quarter July 03, 2024 Via Benzinga Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352) July 01, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs) June 10, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) June 03, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) May 06, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024 May 02, 2024 Via InvestorPlace Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 April 03, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) April 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates March 12, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) March 01, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) February 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February February 01, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher January 17, 2024 Via The Motley Fool Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 26, 2024 Via Benzinga Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know January 16, 2024 Via Benzinga Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares January 08, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire This biotech stock has surged over 300% this week January 05, 2024 Via MarketBeat Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
